医师整体判断能否预测可切除胰腺导管腺癌患者的生存
本研究让10名外科医师和2名放射科医师基于20例已切除胰腺导管腺癌患者的术前临床特征和常规CT预测2年总生存,全体医师AUC为0.707(95%CI 0.642-0.772),放射科医师AUC为0.875高于外科医师的0.656,除一名医师外均优于临床列线图的AUC 0.604。
要点
- 医师整体判断预测可切除PDAC患者2年总生存的全体AUC为0.707(95%CI 0.642-0.772)。
- 放射科医师AUC为0.875(95%CI 0.765-0.985),高于外科医师的0.656(95%CI 0.580-0.732)。
- 除一名医师外,所有医师的预测均优于临床列线图(AUC 0.604)。
核心结论
- 这项先导研究显示医师整体判断的量化具有显著前景,医师尤其是临床经验更丰富和具有影像学专长者预测2年生存的准确性高于现有列线图。
研究设计与样本
- 先导研究,10名外科医师和2名放射科医师对20例已切除胰腺导管腺癌患者,基于术前临床特征(年龄、性别、症状、可获取的术前CA19-9)和常规CT预测2年总生存概率,以受试者工作特征曲线评估并与本机构建立的列线图比较。
诊断标准与关键数值
- 全体医师预测2年总生存的AUC为0.707(95%CI 0.642-0.772);从业超过5年的主治医师AUC为0.710(95%CI 0.536-0.884),从业不足5年的医师AUC为0.662(95%CI 0.398-0.927);放射科医师AUC为0.875(95%CI 0.765-0.985),外科医师AUC为0.656(95%CI 0.580-0.732);临床列线图AUC为0.604。
临床应用与阅片要点
- 作者认为医师整体判断在预测可切除胰腺导管腺癌患者2年总生存方面具有量化前景,尤其临床经验更丰富和具有影像学专长的医师准确性更高。
局限性
- 原文将该研究描述为先导研究。
- 原文指出胰腺导管腺癌仍是难以进行预后判断的疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Clinician gestalt may hold unexplored information that can be capitalized upon to improve existing nomograms. The study objective was to evaluate physician ability to predict 2-year overall survival (OS) in resected pancreatic ductal adenocarcinoma (PDAC) patients based on pre-operative clinical characteristics and routine CT imaging.
METHODS: Ten surgeons and two radiologists were provided with a clinical vignette (including age, gender, presenting symptoms, and pre-operative CA19-9 when available) and pre-operative CT scan for 20 resected PDAC patients and asked to predict the probability of each patient reaching 2-year OS. Receiver operating characteristic curves were used to assess agreement and to compare performance with an established institutional nomogram.
RESULTS: Ten surgeons and 2 radiologists participated in this study. The area under the curve (AUC) for all physicians was 0.707 (95% CI 0.642-0.772). Attending physicians with > 5 years experience performed better than physicians with < 5 years of clinical experience since completion of post-graduate training (AUC = 0.710, 95% CI [0.536-0.884] compared to AUC = 0.662, 95% CI [0.398-0.927]). Radiologists performed better than surgeons (AUC = 0.875, 95% CI [0.765-0.985] compared to AUC = 0.656, 95% CI [0.580-0.732]). All but one physician outperformed the clinical nomogram (AUC = 0.604).
CONCLUSIONS: This pilot study demonstrated significant promise in the quantification of physician gestalt. While PDAC remains a difficult disease to prognosticate, physicians, particularly those with more clinical experience and radiologic expertise, are able to perform with higher accuracy than existing nomograms in predicting 2-year survival.
引用
- Pak LM, Gonen M, Seier K, et al. Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? Abdom Radiol (NY). 2018. PMID: 29177926. doi:10.1007/s00261-017-1407-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。